A substance called epidermal growth factor receptor, which has been associated with higher mortality rates in cancers of the head and neck, has now been linked to higher death rates in breast cancer patients.
A substance called epidermal growth factor receptor, which has been associated with higher mortality rates in cancers of the head and neck, has now been linked to higher death rates in breast cancer patients.
